The U.S. Food and Drug Administration (FDA) has granted priority review status to the application seeking approval of Tyvaso DPI...
Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual Living...
A combination of lung injury and increased activation of B-cells — immune cells responsible for antibody production — was sufficient...
Pride Month, observed each June, is a time to celebrate LGBTQ history, community, and life through events and parades. Curiously...
Throughout my son Cullen’s pulmonary hypertension and heart-lung transplant journey, it has been my impression that hospitals try to treat...
United Therapeutics is a company on a mission to continuously advance the care for pulmonary arterial hypertension (PAH). Remodulin® has...
Despite a high-risk of serious complications, 10 women with moderate to severe pulmonary arterial hypertension (PAH) had a successful pregnancy...
A three-month unsupervised health intervention based on a commercial activity tracker and motivational texts significantly increased daily step counts and...
I still remember sitting on the couch with my mom on the eve of my 15th birthday. We were talking...
Do you find yourself scrolling through emails or multitasking when you sit down to rest? If you can’t seem to...
A new metric for assessing cardiac health, called pulmonary artery proportional pulse pressure or PAPP, could help to identify people...
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for rare diseases...